Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
Part of
MarketBeat provided analyst recommendations for companies listed on the Nasdaq exchange.Also in this story
- MarketBeat reported analyst recommendations for AMCI Acquisition Corp., which is listed on the Nasdaq electronic stock exchange.
- Versant was listed on the electronic stock exchange and received analyst recommendations from MarketBeat.
The entities involved
-
MarketBeat
American personal finance blog
-
Nasdaq
American fully electronic stock exchange
Related events
- BioMarin Pharmaceutical and CollPlant Biotechnologies were listed on Nasdaq and are being compared as healthcare companies.
- Kiora Pharmaceuticals and Spero Therapeutics Inc. are listed on Nasdaq, with MarketBeat providing analyst ratings for Spero.
- Earnings reports from major tech companies like Alphabet and ServiceNow led to stock drops and reduced forecasts.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Eton Pharmaceuticals and Biofrontera, small-cap healthcare companies, are noted for their revenue and earnings, with MarketBeat providing analyst ratings.